What is the generic name?

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN

What is the Trade Name for LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN?

PLUVICTO

What are the Indications for LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN?

• 1 INDICATIONS AND USAGE PLUVICTO is indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy. PLUVICTO is a radioligand therapeutic agent indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy. ( 1 )

References: https://open.fda.gov/